Institutional Fund
Fcpm III Services B.V.
Naarden, NetherlandsCIK 20134105 filings on record
Portfolio Value
$722.21M
Q1 2026
Holdings
10
Reported positions
New Buys
1
Opened this quarter
QoQ Change
-5.3%
from $762.89M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Newamsterdam Pharma Company40.8%
- Dyne Therapeutics Inc11.7%
- Vor Biopharma Inc10.2%
- Engene Holdings Inc9.1%
- Maplight Therapeutics Inc9.1%
- Galecto Inc8.8%
- Other10.5%
Portfolio Holdings
10 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Newamsterdam Pharma Company | 9.20M | $294.46M | 40.8% | 0 | Held |
| 2 | Dyne Therapeutics Inc | 4.64M | $84.20M | 11.7% | −818.5K | Reduced |
| 3 | Vor Biopharma Inc | 4.12M | $73.45M | 10.2% | +500.0K | Added |
| 4 | Engene Holdings Inc | 9.63M | $65.60M | 9.1% | 0 | Held |
| 5 | Maplight Therapeutics Inc | 3.23M | $65.59M | 9.1% | 0 | Held |
| 6 | Galecto Inc | 2.44M | $63.22M | 8.8% | +2.44M | New |
| 7 | Crescent Biopharma Inc. | 1.68M | $30.82M | 4.3% | 0 | Held |
| 8 | Replimune Group Inc | 2.81M | $21.48M | 3.0% | 0 | Held |
| 9 | Bicycle Therapeutics PLC | 3.47M | $16.09M | 2.2% | 0 | Held |
| 10 | Engene Holdings Inc | 2.88M | $7.28M | 1.0% | 0 | Held |